Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients A Pragmatic Trial (EVOLUTION).

Brief description of study

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients, A Pragmatic Trial (EVOLUTION).


Clinical Study Identifier: s23-00181
ClinicalTrials.gov Identifier: NCT05669833
Principal Investigator: Soumya M Reddy.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.